News

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

Ultromics EchoGo Amyloidosis artificial intelligence

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

Bayer finerenone Kerendia heart failure MOONRAKER

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.

Thumbnail

“Leaders in radiology must prioritize embedding a culture of feedback within their institutions, recognizing its crucial role in continuous improvement," experts charge. 

Jobs hiring talent people human resources

Findings are from a survey of 18,000 physicians across 43 states and working at over 100 healthcare organizations, who participated in the AMA Organizational Biopsy.

Achala Vagal MD University of Cincinnati

Selected through a national search, Achala Vagal, MD, will take on the title Aug. 1, bringing more than 20 years of experience serving the same school. 

M&A mergers and acquisitions business deal

The first phase of Kaiser Permanente’s rollout of Risant Health has been completed, as the new nonprofit organization has officially closed its blockbuster acquisition of Geisinger Health.

Eko Health, the California-based healthcare technology company known for its advanced stethoscopes, has received U.S. Food and Drug Administration (FDA) approval for a new artificial intelligence (AI) offering designed to detect low ejection fraction (EF).

Eko Health worked closely with Mayo Clinic to develop and evaluate its latest AI offering. “Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations," one clinician said. 

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.

microsoft building

Buzzworthy developments of the past few days.

Around the web

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.